<DOC>
	<DOCNO>NCT00768482</DOCNO>
	<brief_summary>This study measure amount buprenorphine find blood take sublingual buprenorphine tablet versus implantation 4 Probuphine ( buprenorphine implant ) .</brief_summary>
	<brief_title>A Bioavailability Safety Study Probuphine Versus Sublingual Buprenorphine Patients With Opioid Dependence</brief_title>
	<detailed_description>This open-label study intend evaluate relative bioavailability 4 Probuphine implant versus 16mg QD sublingual buprenorphine , determine plasma BPN AUC ( 0-24 ) , 24 hour steady state . This study also provide open-label safety tolerability data patient treated Probuphine .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Voluntarily provide write informed consent prior conduct study relate procedure Male female , 1875 year age Meet DSMIV criterion current opioid dependence Females childbearing potential fertile male must use reliable mean contraception Current diagnosis Acquired Immune Deficiency Syndrome ( AIDS ) Received treatment opioid dependence ( e.g. , methadone , BPN ) within previous 90 day Current diagnosis chronic pain require opioids treatment Candidates short term opioid treatment opioid detoxification therapy Pregnant lactating female Previous hypersensitivity allergy BPN EVAcontaining substances naloxone Current use agent metabolize Cytochrome P450 3A4 ( CYP 3A4 ) azole antifungal ( e.g. , ketoconazole ) , macrolide antibiotic ( e.g. , erythromycin ) , protease inhibitor ( e.g. , ritonavir , indinavir , saquinavir ) Current history coagulopathy , and/or anticoagulant therapy ( warfarin ) Meet DSMIV criterion current dependence psychoactive substance opioids nicotine ( e.g. , alcohol , sedative ) Current use benzodiazepine physician prescribe use Significant medical psychiatric symptom , cognitive impairment , factor opinion Investigators would preclude compliance protocol , patient safety , adequate cooperation study , obtain informed consent Concurrent medical condition ( severe respiratory insufficiency ) may prevent patient safely participate study ; and/or pending legal action could prohibit participation and/or compliance study Participated clinical study within previous 8 week Previous participation Probuphine clinical trial Presence aspartate aminotransferase ( AST ) level great equal 3 X upper limit normal and/or alanine aminotransferase ( ALT ) level great equal 3 X upper limit normal and/or total bilirubin great equal 1.5 X upper limit normal and/or creatinine great equal 1.5 X upper limit normal Clinically significant low platelet count current history coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>opioid dependence</keyword>
	<keyword>opioid addiction</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>methadone</keyword>
	<keyword>heroin</keyword>
	<keyword>implant</keyword>
	<keyword>opioid withdrawal</keyword>
	<keyword>opioid pain medication</keyword>
	<keyword>suboxone</keyword>
</DOC>